Trials / Completed
CompletedNCT00289276
FAST (Fluid Accumulation Status Trial)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 156 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. Using very low electrical pulses that travel across the inside of the chest cavity, thoracic fluid status monitoring (OptiVol™) can measure the level of resistance to the electrical pulses, which indicates the level of fluid in the chest. The purpose of this study is to collect information related to fluid build up in the chest of subjects with heart failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fluid Status Monitoring (OptiVol™) | Thoracic Fluid Status Software downloaded on all subjects enrolled in the trial |
Timeline
- Start date
- 2003-11-01
- Primary completion
- 2008-04-01
- First posted
- 2006-02-09
- Last updated
- 2010-10-13
- Results posted
- 2010-09-28
Locations
16 sites across 3 countries: United States, Canada, China
Source: ClinicalTrials.gov record NCT00289276. Inclusion in this directory is not an endorsement.